24th Jun 2019 7:00 am |
RNS |
Motif Bio Presents New Iclaprim Data - ASM Microbe |
20th Jun 2019 4:35 pm |
RNS |
Price Monitoring Extension |
19th Jun 2019 5:08 pm |
RNS |
Holding(s) in Company |
18th Jun 2019 4:05 pm |
RNS |
Holding(s) in Company |
14th Jun 2019 9:04 am |
RNS |
Holding(s) in Company |
12th Jun 2019 5:52 pm |
RNS |
Holding(s) in Company |
6th Jun 2019 7:00 am |
RNS |
Receipt of FDA Meeting Minutes |
31st May 2019 3:15 pm |
RNS |
Result of AGM |
31st May 2019 10:28 am |
RNS |
Holding(s) in Company |
29th May 2019 11:36 am |
RNS |
Holding(s) in Company |
22nd May 2019 1:50 pm |
RNS |
AGM Statement |
22nd May 2019 7:00 am |
RNS |
Orphan Disease Opportunity for Iclaprim |
21st May 2019 7:00 am |
RNS |
Iclaprim Data presented at ASM Microbe 2019 |
20th May 2019 6:14 pm |
RNS |
Holding(s) in Company |
3rd May 2019 6:25 pm |
RNS |
Meeting with US FDA held as planned |
1st May 2019 7:00 am |
RNS |
Motif Signs Agreement with Lamellar Biomedical |
26th Apr 2019 7:01 am |
RNS |
Notice of AGM |
26th Apr 2019 7:00 am |
RNS |
Appointment of Andrew Powell to Board of Directors |
16th Apr 2019 7:00 am |
RNS |
Motif Presents New Iclaprim Data at ECCMID 2019 |
15th Apr 2019 7:00 am |
RNS |
Fiscal Year 2018 Results |
4th Apr 2019 7:00 am |
RNS |
Motif Bio to Present Iclaprim Data at ECCMID 2019 |
2nd Apr 2019 5:43 pm |
RNS |
Holding(s) in Company |
1st Apr 2019 3:28 pm |
RNS |
Holding(s) in Company |
1st Apr 2019 2:17 pm |
RNS |
Holding(s) in Company |
26th Mar 2019 7:00 am |
RNS |
Motif Bio Raises £2.7m (US$3.55m) |
25th Mar 2019 9:49 am |
RNS |
Proposed Equity Fundraise |
20th Mar 2019 7:00 am |
RNS |
Holding(s) in Company |
20th Mar 2019 7:00 am |
RNS |
Motif Bio Granted Meeting with U.S. FDA |
18th Mar 2019 7:00 am |
RNS |
Appointment of Bruce Williams as Interim Chairman |
15th Mar 2019 7:01 am |
RNS |
Holding(s) in Company |
7th Mar 2019 12:07 pm |
RNS |
Second Price Monitoring Extn |
7th Mar 2019 12:02 pm |
RNS |
Price Monitoring Extension |
19th Feb 2019 7:00 am |
RNS |
Conference Call and Webcast |
18th Feb 2019 7:00 am |
RNS |
Amendment Agreement with Hercules Capital |
15th Feb 2019 4:28 pm |
RNS |
Holding(s) in Company |
15th Feb 2019 4:26 pm |
RNS |
Holding(s) in Company |
14th Feb 2019 7:00 am |
RNS |
Complete Response Letter from the FDA |
5th Feb 2019 7:00 am |
RNS |
Exercise of Warrants |
23rd Jan 2019 4:31 pm |
RNS |
Exercise of Warrants |
1st Nov 2018 4:40 pm |
RNS |
Second Price Monitoring Extn |